Salvage therapy for refractory hemophagocytic lymphohistiocytosis: A review of the published experience.

导出原文传递

翻译打印收藏纠错

第一作者： Rebecca A,Marsh

第一单位： Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children's Hospital, Cincinnati, Ohio.

作者： Rebecca A,Marsh ^[1] ; Michael B,Jordan ^[2] ; Julie-An,Talano ^[3] ; Kim E,Nichols ^[4] ; Ashish,Kumar ^[1] ; Ahmed,Naqvi ^[5] ; Sarah R,Vaiselbuh ^[6] ; Histiocyte Society Salvage Therapy Working Group

作者单位： Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children's Hospital, Cincinnati, Ohio. ^[1] Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children's Hospital, Cincinnati, Ohio.;Division of Immunobiology, Cincinnati Children's Hospital, Cincinnati, Ohio. ^[2] Division of Pediatric Hematology and Oncology Medical College of Wisconsin, Milwaukee, Wisconsin. ^[3] Division of Cancer Predisposition, St. Jude Children's Research Hospital, Memphis, Tennessee. ^[4] Division of Haematology/Oncology, Department of Pediatrics, The Hospital for Sick Children, Toronto, Ontario. ^[5] Children's Cancer Center, Staten Island University Hospital at Northwell Health, Staten Island, New York. ^[6]

关键词 HLH hemophagocytic lymphohistiocytosis refractory HLH salvage therapy

主题词抗药性, 肿瘤(Drug Resistance, Neoplasm);药物疗法, 联合(Drug Therapy, Combination);人类(Humans);淋巴组织细胞增多症, 嗜血细胞性(Lymphohistiocytosis, Hemophagocytic);预后(Prognosis);挽救疗法(Salvage Therapy)

DOI 10.1002/pbc.26308

PMID 27786410

发布时间 2020-07-23

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交